Technology | June 10, 2009

MDS Nordion Manufactures CardioGen-82 Cardiac Imaging Agent

June 10, 2009 – MDS Nordion said today it commenced the manufacture of CardioGen-82 (rubidium Rb 82 generators) for Bracco Diagnostics Inc.

MDS Nordion has designed and built a dedicated manufacturing suite within its FDA-approved, Good Manufacturing Practices-compliant production facility in Ottawa. Production of CardioGen-82 began yesterday.

CardioGen-82, the only generator-based, cardiac Positron Emission Tomography (PET) perfusion imaging agent approved by the FDA, produces Rb-82 using a specialized generator technology. Once administered to the patient, Rb-82 is used as a PET imaging tracer for perfusion studies of the heart to examine blood flow through heart vessels. PET is a highly sensitive medical imaging technique that produces a three-dimensional image of the functioning heart, allowing the cardiologist to identify regions of the heart muscle receiving poor blood flow.

For more information: www.braccoimaging.com, www.mdsnordion.com, www.mdsintl.com


Additional Content

Feature | Nuclear Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

Home November 12, 2025
Home
News | Nuclear Imaging

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC ...

Home August 03, 2023
Home
News | Nuclear Imaging

January 5, 2023 — A new study has determined that approximately three percent of all bone scan patients have markers of ...

Home January 05, 2023
Home
News | Nuclear Imaging

April 13, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear ...

Home April 13, 2022
Home
Videos | Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D., MASNC, FASE, FSCCT, director of cardiac ...

Home February 01, 2022
Home
Subscribe Now